Why Inspire Medical Systems Inc’s (INSP) Stock Is Up 11.26%

By Cynthia McLaughlin
September 04, 2024
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Inspire Medical Systems Inc before investing.

In this article, we go over a few key elements for understanding Inspire Medical Systems Inc’s stock price such as:

  • Inspire Medical Systems Inc’s current stock price and volume
  • Why Inspire Medical Systems Inc’s stock price changed recently
  • Upgrades and downgrades for INSP from analysts
  • INSP’s stock price momentum as measured by its relative strength

About Inspire Medical Systems Inc (INSP)

Before we jump into Inspire Medical Systems Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.

Want to learn more about Inspire Medical Systems Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Inspire Medical Systems Inc.

Learn More About A+ Investor

Inspire Medical Systems Inc’s Stock Price as of Market Close

As of September 04, 2024, 4:00 PM, CST, Inspire Medical Systems Inc’s stock price was $197.01.

Inspire Medical Systems Inc is up 11.26% from its previous closing price of $177.07.

During the last market session, Inspire Medical Systems Inc’s stock traded between $176.07 and $181.48. Currently, there are 29.73 million shares of Inspire Medical Systems Inc stock available for purchase.

Inspire Medical Systems Inc’s price-earnings (P/E) ratio is currently at 915.0, which is high compared to the Medical Equipment, Supplies & Distribution industry median of 41.3. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Inspire Medical Systems Inc Stock Price History

Inspire Medical Systems Inc’s (INSP) price is currently up 9.56% so far this month.

During the month of September, Inspire Medical Systems Inc’s stock price has reached a high of $197.96 and a low of $176.07.

Over the last year, Inspire Medical Systems Inc has hit prices as high as $257.40 and as low as $123.00. Year to date, Inspire Medical Systems Inc’s stock is down 21.78%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Inspire Medical Systems Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 03, 2024, there were 6 analysts who downgraded Inspire Medical Systems Inc’s stock and 10 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Inspire Medical Systems Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Inspire Medical Systems Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Inspire Medical Systems Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Inspire Medical Systems Inc (INSP) by visiting AAII Stock Evaluator.

Relative Price Strength of Inspire Medical Systems Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 03, 2024, Inspire Medical Systems Inc has a weighted four-quarter relative price strength of -4.56%, which translates to a Momentum Score of 47 and is considered to be Average.

Want to learn more about how Inspire Medical Systems Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Inspire Medical Systems Inc Stock Price: Bottom Line

As of September 4, 2024, Inspire Medical Systems Inc’s stock price is $197.01, which is up 11.26% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Inspire Medical Systems Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
Est Rev: Up 5% Screen: 21.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.